Adrian Jimenez

Neurosurgery Resident @ColumbiaNeuro @nyphospital

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Check out our new survey by @jimenezae17 + assessing QOL outcomes in #Chordoma patients!

We find that younger survivors, female survivors, and survivors currently undergoing treatment for chordoma are at high risk for adverse #QOL outcomes

Great work!

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here in @NeurosurgeryCNS,

@jimenezae17 + @tdazad performed a study with the Medicare Physician/ Supplier Procedure Summary

They reveal an increase in endoscopic transphenoidal surgery claims and a decrease in microscopic transphenoidal surgery claims from 2010-2020

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here in #ClinicalNeurologyandNeurosurgery, @KhalafallahAM+ introduces a new #socioeconomic educational intervention for improving socioeconomic knowledge among #neurosurgery trainees.

Read more here! https://t.co/oDVJwCQK24

@Sach_Chak @jlporrasMD @KuoCathleen @jimenezae17

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here,@jimenezae17 used #Bayesian methods to characterize post-op #outcomes in #frailty patients

mFI-5 scores may be useful in predicting short term #outcomes but not long term outcomes such as 90-day mortality
https://t.co/ZnYjuf1Y7O

@WorldNeurosurg @ColumbiaNeuro @HopkinsNsurg

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Very excited for this special #Meningioma issue in #Neurosurgery Clinics

Thank you @DoctorZada & @rljensenmdphd for the opportunity to contribute

+ thank you to all additional contributing authors for making this a great issue! #Braintumor #Braincancer #BTAM #BTSM

[Johns Hopkins Neurosurgery @HopkinsNsurg]

Join us in congratulating Dr. Amir Manbachi @AManbachi & Dr. Debraj Mukherjee @NeuroOncSurgery recipients of 2023 Johns Hopkins Catalyst Awards! They are among 37 other early career faculty members to receive this honor from @JohnsHopkins. 👏👏Amir & Raj https://t.co/Ql8PCtLs0R

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Congrats @jimenezae17+ for publishing results from the @ChordomaFDN survivorship survey

Younger co-survivors may be at higher risk for adverse emotional #QOL outcomes while 1/3rd of co-survivors do not know about available resources @WorldNeurosurg

Link: https://t.co/mxEzYJNmIe

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here in @TheJNS,

@jimenezae17 and @Rrkotecha provide insight on key issues of clinical trial implementation in #NSGY

Futures workflows should include pre-pipeline discussions, joint feasibility meetings and final approval by an IRB

Great work!
Link: https://t.co/YsAuGCq1TR

[Adrian Jimenez @jimenezae17]

@JulianGendreau Thanks Julian!!

[Adrian Jimenez @jimenezae17]

@migueangjim Thanks so much Miguel, means a ton!! Looking forward to more collaborations in the future!

[Columbia Neurosurgery @ColumbiaNeuro]

Congratulations to our 2023 Columbia Neurosurgery matches! Michael G. Argenziano, MS, MD, Adrian Jimenez MD, and Amitra K. Singh, MD!

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here,@JulianGendreau + @HameedFarrukh @jimenezae17 @YusufMehkri find fractionated RT offers unclear benefit at improving progression-free survival in clival Chordoma patients that achieve gross total resection

Further investigation is needed! @NeurosurgeryCNS @ChordomaFDN

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here, stellar med students @jimenezae17 + @pav_shah and residents @jlporrasMD + @tdazad developed ML models for predicting prolonged LOS, nonroutine discharges and high hospital charges for #skullbase meningioma patients
#JNLSB @NASBSorg

Check it out! https://t.co/NR68eUcW7V

[Tej D. Azad 🇺🇸 @tdazad]

Our latest in @NeurosurgeryCNS , work led by all star @HopkinsMedicine student @AndrewHersh96 and post bacc @tara_dedrickson, great @HopkinsNsurg @StanfordNsurg collab. @jimenezae17 @JoshuaDMateri @AnandMed @councilsns

Insightful comments via @DrDiGiorgio @NeurosurgUCSF

[Journal of Neurosurgery @TheJNS]

#OnlineFirst: A comparative analysis of the Hospital Frailty Risk Score in predicting postoperative outcomes among intracranial tumor patients https://t.co/BbNcqZWF04

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Here in @TheJNS,
@jimenezae17,@migueangjim+colleagues show the Hospital Frailty Risk Score may be a more effective predictor of adverse outcomes when compared to ASA, CCI, mFI-11 and mFI-5.

Measured outcomes were post-op complications, extended LOS, 90-day readmission and more!

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Utilizing the SEER database, @JulianGendreau, @jimenezae17, @KuoCathleen + collaborators from multiple institutions find unclear outcomes of using RT after achieving GTR for skull base chordoma patients. @WorldNeurosurg

More studies are needed!

Link: https://t.co/YaIyJEJDRY

[NASBS @NASBSorg]

#JNLSB_Online
Machine Learning Models for Predicting Postoperative Outcomes following Skull Base Meningioma Surgery

#nsgy #skullbase #meningioma #machinelearning @HopkinsNsurg

https://t.co/vPJiletdI1

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

Excited to present our work @CNS_Update #CNS2022!

1st authors from our team included @RakovecMaureen @jimenezae17 @JulianGendreau

Grateful to @arasthagiri @lola_chambless @GarniBDarian for organizing, and looking forward to reconnecting with friends from around the world!

[Johns Hopkins Neuro-Oncology Surgical Outcomes Lab @NeuroOncSurgery]

284 million+ people worldwide suffer substance use disorders (SUDs), increasingly affecting #nsgy patients

@jimenezae17 @jlporrasMD @tdazad+ found SUDs significantly impacted readmission after #braintumor surgery #btsm

Check out results @WorldNeurosurg!
https://t.co/D5THTKlvFR